Long-term data from a landmark international trial show that about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors live cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre i
According to a new report from Weill Cornell Medicine and Dana-Farber Cancer Centre investigators and their colleagues, long-term data from a landmark international trial show that approximately half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibit
Madrid [Spain], July 18 (ANI): Scientists, during a recent study discovered combining BRAF oncogene inhibitors and chemotherapy, is a very effective strategy for fighting metastatic melanoma, which is the leading cause of death from skin cancer around the globe.
Madrid [Spain], July 13 (ANI): During a recent study, researchers found that combining BRAF oncogene inhibitors and chemotherapy is a very effective strategy for fighting metastatic melanoma, which is the leading cause of death from skin cancer around the globe.
Washington D.C. [U.S.A], Oct. 8 (ANI): In a recent study, a group of researchers found a link between an individual's gut bacteria and their response to anticancer immune checkpoint inhibitor therapy (ICT).